Obesity is increasing rapidly throughout the world, and is predicted to double by 2025. Bariatric surgery has shown promising results, but a need for a safe and more effective procedure exists. In the last decade, there have been many publications confirming that Mini-Gastric Bypass (MGB) is a safer and equally or more effective alternative to the traditional Roux-en-Y gastric bypass. MGB has shown stronger metabolic control and more durable weight loss than the traditional bariatric operations.
The proposed mechanism behind this sustained weight loss and effective control of the metabolic syndrome is a longer biliopancreatic limb and the long gastric pouch with a wide gastric outlet, giving a low-pressure tube and thus reducing the chances of leak, nausea, and reflux in the immediate post-operative period. There are also fewer chances of dilatation in the long-term for the same reason.
The delivery of food without obstruction enables the food to be dropped into the distal jejunum, thus causing a transient dilatation of the gut and thereby giving a feeling of satiety. This mechanism may be called “non-obstructive restriction of the MGB.” Other mechanisms working behind the MGB are the gut hormones, incretins, and changes in the gut flora.
Although initially there was strong skepticism of the MGB, now the safety, durability, and reversibility of the MGB is well accepted. With this comes the understanding of the special mechanisms, justifying the multiple published good results of MGB.
Mini-gastric bypass One anastomosis gastric bypass Bariatric surgery Dumping syndrome Type 2 diabetes
This is a preview of subscription content, log in to check access.
Atallah R, Filion KB, Wakil SM, et al. Long-term effects of 4 popular diets on weight loss and cardiovascular risk factors: a systematic review of randomized controlled trials. Circ Cardiovasc Qual Outcomes. 2014;7:815–27.CrossRefPubMedGoogle Scholar
Leblanc ES, O’Connor E, Whitlock EP, et al. Effectiveness of primary care-relevant treatments for obesity in adults: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2011;155:434–47.CrossRefPubMedGoogle Scholar
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta analysis. JAMA. 2004;292:1724–37.CrossRefPubMedGoogle Scholar
Lee WJ, Ser KH, Lee YC, Tsou JJ, Chen SC, Chen JC. Laparoscopic Roux-en-Y vs mini-gastric bypass for the treatment of morbid obesity: a 10-year experience. Obes Surg. 2012;22:1827–34.CrossRefPubMedGoogle Scholar
Dorman RB, Ikramuddin S. Laparoscopic Roux-en-Y gastric bypass: techniques and outcomes. In:The SAGES manual. New York: Springer. p. 13–25.CrossRefGoogle Scholar
Hall JE. Guyton and hall textbook of medical physiology, Unit XII, gastrointestinal physiology. Elsevier: Philadelphia, PA; 2015. p. 834.Google Scholar
Odstrcil EA, Martinez JG, Santa Ana CA, Xue B, Schneider RE, Steffer KJ, Porter JL, Asplin J, Kuhn JA, Fordtran JS. The contribution of malabsorption to the reduction in net energy absorption after long-limb Roux-en-Y gastric bypass. Am J Clin Nutr. 2010;92:704–13.CrossRefPubMedGoogle Scholar
Svanevik M, Risstad H, Hofsø D, Schou CF, Solheim B, Søvik TT, Kristinsson J, Hjelmesæth J, Mala T, Sandbu R. Perioperative outcomes of proximal and distal gastric bypass in patients with BMI ranged 50–60 kg/m2 – A double-blind, randomized controlled trial. Obes Surg. 2015;25:1788–95.CrossRefPubMedPubMedCentralGoogle Scholar
Jammu GS, Sharma R. A 7-year clinical audit of 1107 cases comparing sleeve gastrectomy, Roux-en-Y gastric bypass, and mini-gastric bypass, to determine an effective and safe bariatric and metabolic procedure. Obes Surg. 2016;26:926–32.CrossRefGoogle Scholar
Suárez Llanos JP, Fuentes Ferrer M, Alvarez-Sala-Walther L, García Bray B. Medina González L4 Bretón Lesmes I, Moreno Esteban B. Protein malnutrition incidence comparison after gastric bypass versus biliopancreatic diversion. Nutr Hosp. 2015;32:80–6.PubMedGoogle Scholar
Ukleja A. Nutrition issues in Gastroenterology, series #35, Integrative Nutrition Therapy. 2016. p 270.Google Scholar
Nannipieri M, Mari A, Anselmino M, et al. The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery. J Clin Endocrinol Metab. 2011;96:e1372–9.CrossRefPubMedGoogle Scholar
Cummings DE. Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery. Int J Obes (Lond). 2009;33:S33–40.CrossRefGoogle Scholar
Lee WJ, Chong K, Lin YH, Wei JH, Chen SC. Laparoscopic sleeve gastrecomy versus single anastomosis (mini-) gastric bypass for the treatment of type 2 diabetes mellitus: 5-year results of a randomized trial and study of incretin effect. Obes Surg. 2014;24:1552–62.CrossRefPubMedGoogle Scholar
Troseid M, Nestvold TK, Rudi K, Thoresen H, Nielsen EW, Lappegard KT. Plasma lipopolysaccharide is closely associated with glycemic control and abdominal obesity: evidence from bariatric surgery. Diabetes Care. 2013;36:3627–32.CrossRefPubMedPubMedCentralGoogle Scholar
Patti ME, Houten SM, Bianco AC, et al. Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity. 2009;17:1671–7.CrossRefPubMedGoogle Scholar
Kashyap S, Daud S, Kelly KR, et al. Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. Int J Obes (Lond). 2010;34:462–71.CrossRefGoogle Scholar
Liou AP, Paziuk M, Luevano JM, Machineni S, Turnbaugh PJ, Kaplan LM. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med. 2013;5(178):178ra41.CrossRefPubMedPubMedCentralGoogle Scholar
Gasbarrini A, Corazza GR, Gasbarrini G, et al. Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther. 2009;29(Suppl 1):1–49.PubMedGoogle Scholar